What Does “Rules Are Still Being Written” Mean for CBD Buyers?
“Rules are still being written” can sound like a soft-focus way of saying nobody knows what they’re doing. For CBD shoppers, it has a more practical meaning: federal regulators have not established a comprehensive set of rules for many CBD products sold as foods or supplements, while state laws and product quality vary. That leaves buyers navigating a market where a polished package can look more certain than the regulations behind it.
The uncertainty also sits inside a wider change in consumer culture. Luxury is moving from special-occasion dressing toward the clothes, products, and environments people use every day. Wellness language has crossed into fashion branding. Comfort is no longer an afterthought; fabric hand, seamless construction, and small sensory details can make or break a purchase. In that setting, a CBD product may be presented with the same quiet confidence as a premium sweatshirt or skincare line. But refined branding is not a substitute for documentation.
Here’s what CBD regulation uncertainty means in practice—and how to do shopper due diligence without confusing a beautiful label for a reliable one.
What regulators have—and haven’t—said
CBD, or cannabidiol, is a compound found in cannabis and hemp. The 2018 Farm Bill removed hemp, as defined by the law, from the federal Controlled Substances Act. That change helped make hemp-derived CBD products more widely available. It did not create blanket approval for CBD in foods, dietary supplements, or medical products.
The U.S. Food and Drug Administration (FDA) still has authority over products making claims about health, food, drugs, and cosmetics. In January 2023, the FDA said that existing food and dietary-supplement frameworks were not appropriate for CBD and that it would work with Congress on a potential new regulatory pathway. The agency cited concerns including possible liver injury, interactions with medicines, and risks for certain populations. The phrase FDA 2023 CBD is useful shorthand for that policy moment—not evidence that a new, comprehensive federal CBD framework was completed then.
That distinction matters. The FDA has approved a prescription CBD medicine for specific uses, but that is not the same as approving every CBD oil, gummy, drink, or skin product on a store shelf. A company’s claim that a product is “FDA registered,” where applicable, should not be read as proof that the FDA has reviewed and approved the product’s safety or effectiveness.
Why “legal” can be an incomplete answer
Shoppers often ask whether CBD is legal. The answer can depend on the product, its ingredients, how it is marketed, and where it is sold. State laws may add restrictions or requirements. Product categories matter, too: a topical product, a beverage, and a product marketed to treat a medical condition can raise different regulatory questions.
Be especially cautious with claims that a product treats anxiety, pain, insomnia, inflammation, or another medical condition. Those are not just lifestyle descriptions; they can be drug claims. A calm-looking package or a mention of “wellness” does not make the claim more substantiated.
Wellness has become part of the fashion vocabulary
Fashion and wellness increasingly share a language of ease, balance, and everyday performance. Brands like lululemon helped normalize clothing that moves between exercise, errands, travel, and home. Luxury, too, has shifted: it is less exclusively about dressing for an occasion and more about making ordinary routines feel considered. The hand of a fabric, a flat seam, or a waistband that stays comfortable through a long day can signal quality more convincingly than a large logo.
CBD branding often borrows from the same visual world. Minimal packaging, muted colors, clean typography, and phrases like “daily calm” can make a bottle feel at home beside a premium skincare serum. Wellness language is now part of fashion branding because both categories sell a promise about how a person wants to feel—not only what they want to own.
That’s where buyers need to separate design from evidence. A clean label can be a useful design choice. It is not a lab result. A “natural” origin story does not tell you how much CBD is in the product, whether it contains THC, or whether contaminants were tested. Quiet status signals—discreet packaging, restrained branding, an understated sense of quality—can be appealing, but they should not function like a logo that asks https://smoothdecorator.com/whats-the-link-between-calm-homes-and-luxury-now/ you to trust without asking questions.
Shopper due diligence: check the parts that don’t show on the front label
Good shopper due diligence is not about becoming a chemist. It is about looking for specific information and noticing when a brand leaves basic questions unanswered. Start with the product itself, then look for evidence that can be tied to the batch you are buying.
- Find the amount of CBD per serving and per package. Check whether the label distinguishes CBD from total hemp extract. Those amounts are not automatically interchangeable.
- Look for a batch-specific certificate of analysis (COA). It should match the lot number on the package, come from an identifiable laboratory, and show results—not just a general statement that testing occurred.
- Read what the test covers. Useful reports may include cannabinoid potency and screening for contaminants such as pesticides, heavy metals, residual solvents, and microbial hazards. A potency result alone is not a complete safety picture.
- Check the THC information. “Hemp-derived” does not tell you everything about THC content. Review the COA and consider workplace, travel, and drug-testing implications.
- Read the full ingredient list and serving directions. Pay attention to added sugars, allergens, carrier oils, flavorings, and other active ingredients—especially in gummies and drinks.
- Look for a real company contact and clear policies. A seller should be reachable and able to answer ordinary questions about sourcing, testing, and the product’s intended use.
- Ask a clinician or pharmacist about medicine interactions. CBD may interact with medications. If you are pregnant, breastfeeding, managing a health condition, or buying for a child, do not rely on general marketing copy for safety guidance.
Make the evidence easy to find
A well-run brand does not make customers hunt through a maze of vague claims to find a test report. The COA should be accessible from the product page or a clearly labeled testing page, and the batch number should be easy to match. If the brand provides a QR code, check that it leads to the report for your lot—not a generic explanation of what testing means.
This is also a useful way to read online brand presentation. A Squarespace-hosted site, for example, may use a familiar structure: product pages, an author page link style, and images delivered through squarespace-cdn URLs. Those site details can make a small brand feel tidy and established. They tell you about the site’s publishing setup, not whether a CBD product meets a safety standard. Treat the presentation as navigation, not verification.
Editorial pages can help readers understand a product category, but they are not a substitute for primary documentation either. PAGE Magazine’s wellness and fashion coverage, including Reverie PAGE, can sit naturally alongside conversations Visit this site about everyday luxury and consumer habits. A link such as the author page helps readers see who is writing; a PAGE Reader Survey link invites them to share what they value. Neither link is a product certification. Keep those roles distinct.
Comfort is a useful comparison—not proof
In apparel, the difference between a garment that looks good and one that earns a place in your weekly rotation often comes down to sensory details. Is the fabric soft without feeling flimsy? Are the seams comfortable? Does the garment hold up after washing? Buyers have learned to look beyond a campaign image and consider construction.
CBD deserves the same kind of grounded attention. You cannot assess a tincture by how calm the packaging looks any more than you can judge a pair of leggings by a studio photograph. Ask what is in it, how much is there, which batch was tested, and whether the company can show its work. Comfort and quality may be part of the product experience, but they do not answer regulatory or safety questions.
When to walk away
- The company makes sweeping treatment claims or promises a guaranteed result.
- The COA is missing, outdated, unrelated to the batch, or too incomplete to interpret.
- The label does not clearly state serving size, CBD quantity, or ingredients.
- Customer service cannot explain basic sourcing and testing questions.
- The marketing implies that “natural,” “premium,” or “hemp-derived” means risk-free.
What “still being written” should mean to a buyer
It should mean staying alert, not giving up on the category. The regulatory picture may evolve, and state rules can differ, so check current requirements where you live and buy. In the meantime, a brand’s willingness to publish batch-level lab results is a practical sign of transparency—not a guarantee of safety, but a much better starting point than a smooth slogan.
Everyday luxury is about choosing things that work well in ordinary life. That might mean a seamless layer from lululemon, a quietly designed space, or a CBD product whose maker can answer precise questions. The quietest status signal is not a label that looks expensive. It is a company that makes its sourcing, ingredients, and testing easy to verify.
When the rules are still being written, let the documentation do more of the talking. Read the label, match the batch, question broad wellness promises, and ask a healthcare professional about personal risks. If a company wants your trust, it should be willing to show you more than a beautiful package.